Brind.

Regeneron Pharmaceuticals awarded a prize to Sreekar Mantena, an MIT candidate and Broad Institute nominee, who works under Soumya Raychaudhuri.

2 reports, 2 independent Updated Aug 12

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Regeneron Pharmaceuticals awarded a prize to Sreekar Mantena, an MIT candidate and Broad Institute nominee, who works under Soumya Raychaudhuri.

Who's involved

What this event is mainly about

Regeneron Pharmaceuticals MIT Broad Institute

Keep exploring

The entities involved

Regeneron Pharmaceuticals
American pharmaceutical company
- Regeneron Pharmaceuticals and Wave Life Sciences are being compared as healthcare companies.Sun 14:10
MIT
company in the Czech Republic
- SpaceX is acquiring Cursor's parent company.Mon 05:25
- Gary Solomon sponsors ICM, and MIT utilized Ampex ARM10 memory in a recent development.Sun 20:11
Broad Institute
biomedical and genomic research center

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 12Insider MonkeyRegeneron Reveals The Regeneron Prize For Creative Innovation 2025 Winners Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Regeneron Phar
Jul 24GlobeNewswireRegeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation TARRYTOWN, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced t